UGT1A1 and Nephropathy: In the current study, the mouse group treated with UGT1A1 antisense morpholino, in combination with CsA, induced protection against kidney damage and improvement in renal functions, with a significant (p < 0.05) reduction in both creatinine and urea levels compared with the CsA group.